Born in Leeds, England, Professor James Shapiro obtained his MD at the University of Newcastle-upon-Tyne and trained in Surgery at the University of Bristol UK. James came to Canada in 1993 and completed a surgical fellowship in hepatobiliary oncology and multiorgan transplantation. He completed further surgical fellowships at the University of Maryland, Vancouver BC and in Kyoto Japan, and joined the faculty in 1998.
Transplantation Research Synopsis
Professor Shapiro led the clinical team with the "Edmonton Protocol" islet transplant success,
and was lead
author on the 2000 NEJM study. He was PI on an international trial that replicated the Edmonton success, published in NEJM 2006. As principal investigator on several international islet transplant trial grants, Shapiro has brought in more than $65 million in grant and philanthropic support through the U of A for work on islet transplantation. He has been the recipient of multiple awards, including the Hunterian Medal from the Royal College of Surgeons of England, the Gold Medal in Surgery from the Governor General of Canada, Physician of the Century, and was recently named one of Nature Biotechnology's most remarkable and influential personalities. He was elected Fellow of the Royal Society of Canada in 2012,
and was recently appointed as the Department of Surgery's first Canada Research Council's Chair in Transplantation Surgery and Regenerative Medicine.
Professor Shapiro is a busy clinical hepatobiliary and pancreatic oncology and transplant surgeon, and also maintains an active immunology
/transplant research laboratory. His group is actively researching personalized medicine approaches to pancreatic and other hepatobiliary cancers, with generation
of human tumor
transplantation in immunodeficient mouse models, using a novel pre-vascularized subcutaneous implantation site model.